ストックスクリーナーアプリを入手
2.75
0.36%
-0.010
アフターアワーズ：
2.80
0.05
+1.82%
前日終値:
$2.76
開ける：
$2.77
24時間の取引高:
4.53M
Relative Volume:
0.75
時価総額：
$941.25M
収益：
-
当期純損益:
$-75.80M
株価収益率:
-7.8571
EPS:
-0.35
ネットキャッシュフロー:
$-68.07M
1週間 パフォーマンス:
+19.57%
1か月 パフォーマンス:
+29.11%
6か月 パフォーマンス:
+21.15%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.72
$2.865
1週間の範囲:
$2.18
$2.865
52週間の値動き範囲:
$1.54
$3.455
Nuvation Bio Inc Stock (NUVB) Company Profile
名前
Nuvation Bio Inc
セクター
電話
(415) 754-3517
住所
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
NUVB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.75 | 944.67M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-23 | 開始されました | Citizens JMP | Mkt Outperform |
| 2024-03-27 | アップグレード | Jefferies | Hold → Buy |
| 2024-03-26 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-01-06 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-02 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-04-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2021-03-08 | 開始されました | BTIG Research | Buy |
| 2021-03-08 | 開始されました | Cowen | Outperform |
| 2021-03-08 | 開始されました | Jefferies | Buy |
| 2021-03-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Nuvation Bio Inc (NUVB) 最新ニュース
Why Nuvation Bio Inc. stock attracts strong analyst attentionJuly 2025 Gainers & Verified High Yield Trade Plans - thegnnews.com
Detecting support and resistance levels for Nuvation Bio Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
What institutional flow reveals about Nuvation Bio Inc.Portfolio Value Report & Low Drawdown Trading Strategies - Newser
Nuvation Bio Inc. stock outlook for YEARLayoff News & Growth Focused Stock Reports - Newser
XTX Topco Ltd Buys 44,979 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
What MACD signals say about Nuvation Bio Inc.July 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Does Nuvation Bio Inc. show high probability of reboundJuly 2025 Patterns & Verified Chart Pattern Trade Signals - Newser
Nuvation Bio's Breakthrough FDA-Approved Iprozy and Its Implications for Biotech Growth - AInvest
Transcript : Nuvation Bio Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Exit strategy if you’re trapped in Nuvation Bio Inc.Volume Spike & Fast Exit Strategy with Risk Control - Newser
Chart Patterns Forming a Bullish Setup in Nuvation Bio Inc.2025 Valuation Update & Reliable Price Breakout Signals - kangso.co.kr
Nuvation Bio’s SWOT analysis: stock poised for growth amid challenges - Investing.com
Technical analysis overview for Nuvation Bio Inc. stockPortfolio Risk Summary & Daily Volume Surge Signals - Newser
Nuvation Bio (NUVB.N) Spikes 11.6% Intraday: A Deep Dive Into the Unusual Move - AInvest
Nuvation Bio (NUVB.N) Surges 12.5%—What’s Fueling the Move? - AInvest
Analyzing recovery setups for Nuvation Bio Inc. investorsCEO Change & Free Community Consensus Stock Picks - Newser
Tools to monitor Nuvation Bio Inc. recovery probabilityChart Pattern Strategy with ROI Focus - Newser
Nuvation Bio Inc. (NYSE:NUVB) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - 富途牛牛
Nuvation Bio (NYSE:NUVB) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - Defense World
Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates - MSN
Wall Street Zen Downgrades Nuvation Bio (NYSE:NUVB) to Sell - Defense World
Nuvation Bio shares rise 1.30% after-hours after RBC raised its price target to $7. - AInvest
Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Game-Changer for IDH1 Mutant Glioma - TipRanks
RBC Raises Price Target on Nuvation Bio to $7 From $6, Keeps Outperform, Speculative Risk - MarketScreener
Nuvation Bio Sees Rapid Adoption of IBTROZI, Reports $1.2M in Q2 2025 Sales and $607.7M in Cash Reserves. - AInvest
Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Nuvation Bio Inc (NUVB) Q2 2025 Earnings Call Highlights: Strong IBTROZI Launch and Strategic ... By GuruFocus - Investing.com Canada
Nuvation Bio’s Milestone with FDA Approval of IBTROZI - TipRanks
NUVB Sales Jump 1,043% on Drug Launch - AOL.com
Nuvation Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Nuvation Bio Reports 1,043% YoY Sales Growth, Exceeds Revenue Estimates with $4.8 Million in GAAP Revenue - AInvest
Earnings call transcript: Nuvation Bio Q2 2025 sees steady EPS, stock rises - Investing.com
Nuvation Bio Inc. SEC 10-Q Report - TradingView
Nuvation Bio earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Earnings Flash (NUVB) Nuvation Bio Inc. Reports Q2 Revenue $4.8M - MarketScreener
New Lung Cancer Drug IBTROZI Gains FDA Approval, Reaches 70 Patients in First 7 Weeks - Stock Titan
Nuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses - BioSpace
Nuvation Bio Presents New IBTROZI Data at WCLC and ESMO Congresses - AInvest
What are the latest earnings results for Nuvation Bio Inc.Consistent triple-digit returns - Jammu Links News
What makes Nuvation Bio Inc. stock price move sharplyCapitalize on market trends with confidence - Jammu Links News
Nuvation Bio Inc. Stock Analysis and ForecastDiscover undervalued stocks before they soar - Jammu Links News
Nuvation Bio (NUVB.N) Plunges 5.5%: What’s Behind the Sudden Sell-Off? - AInvest
Nuvation Bio Announces Q2 2025 Financial Results and Business Update on August 7, 2025. - AInvest
What catalysts could drive Nuvation Bio Inc. stock higher in 2025Get real-time alerts on top-performing stocks - Jammu Links News
Nuvation Bio (NUVB.N) Drops 5.5%: What’s Behind the Sudden Slide? - AInvest
How does Nuvation Bio Inc. generate profit in a changing economyFree Investment Case Studies - Jammu Links News
How does Nuvation Bio Inc. compare to its industry peersFree Trend-Following Techniques - Jammu Links News
Is Nuvation Bio Inc. a good long term investmentExceptional financial outcomes - Jammu Links News
What institutional investors are buying Nuvation Bio Inc. stockConsistent wealth multiplication - Jammu Links News
Is Nuvation Bio Inc. a growth stock or a value stockInvest in stocks with long-term growth potential - Jammu Links News
RBC Capital Maintains a Buy on Nuvation Bio (NUVB) With a $6 PT - MSN
Nuvation Bio Inc (NUVB) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):